Document is current
Any future updates will be listed below
-
Authors
Faraone, Stephen V. https://orcid.org/0000-0002-9217-3982
Newcorn, Jeffrey H.
- License Information
-
More Information
Article History
First Online: 5 January 2026
Competing interests
: In the past year, S.V.F. received income, potential income, travel expenses continuing education support and/or research support from Aardvark, Aardwolf, Mentavi/ADHD Online, Ironshore/Collegium, Corium, Johnson & Johnson/Kenvue, Medice, Otsuka, Supernus and Alkermes. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. He also receives royalties from books published by Guilford Press, Oxford University Press and Elsevier. He is program director of the and . J.H.N. is a consultant or on the advisory board for AGB Pharma, Cingulate Therapeutics, Hippo T&C, Lumos, Medice, Mentavi Health, MindTension, Otsuka, Signant Health, Supernus and the US National Football League; has received research support from Cingulate, MindTension and Supernus; and has received honoraria for disease state lectures from Apsen.
